KIN insider filings
Kindred Biosciences, Inc. — 39 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2021-09-13. Screen KIN transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for KIN between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Kindred Biosciences, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2021-09-13 | 4 | Park West Asset Management LLC — 10% owner | Other (J): 6,000,002 | EDGAR |
| 2021-08-30 | 4 | Bevers Denise — Director | Disposition to issuer (D): 145,835 @ $9.25 · Disposition to issuer (D): 20,400 (derivative) @ $8.35 · Disposition to issuer (D): 96,092 (derivative) @ $7.88 · Disposition to issuer (D): 75,000 (derivative) @ $0 · Disposition to issuer (D): 59,031 (derivative) @ $2.29 · Disposition to issuer (D): 59,031 (derivative) @ $5.80 · +7 more | EDGAR |
| 2021-08-30 | 4 | Zhan Hangjun — Chief Scientific Officer | Disposition to issuer (D): 64,306 @ $9.25 · Disposition to issuer (D): 12,000 (derivative) @ $0 · Disposition to issuer (D): 7,500 (derivative) @ $0.08 · Disposition to issuer (D): 8,000 (derivative) @ $2.29 · Disposition to issuer (D): 10,000 (derivative) @ $6 · Disposition to issuer (D): 15,000 (derivative) @ $5.65 · +6 more | EDGAR |
| 2021-08-30 | 4 | Veszpremi Ervin — Director | Disposition to issuer (D): 40,000 (derivative) @ $8.93 · Disposition to issuer (D): 20,000 (derivative) @ $7.88 · Disposition to issuer (D): 35,000 (derivative) @ $0 · Disposition to issuer (D): 44,000 (derivative) @ $2.29 · Disposition to issuer (D): 44,000 (derivative) @ $5.80 · Disposition to issuer (D): 49,900 (derivative) @ $2.85 · +4 more | EDGAR |
| 2021-08-30 | 4 | Townsend Raymond — Director | Disposition to issuer (D): 24,928 @ $9.25 · Disposition to issuer (D): 20,000 (derivative) @ $2.25 · Disposition to issuer (D): 34,000 (derivative) @ $0 · Disposition to issuer (D): 44,000 (derivative) @ $2.29 · Disposition to issuer (D): 18,892 (derivative) @ $5.80 · Disposition to issuer (D): 49,900 (derivative) @ $2.85 · +4 more | EDGAR |
| 2021-08-30 | 4 | McCracken Joseph S — Director | Disposition to issuer (D): 41,890 (derivative) @ $0 · Disposition to issuer (D): 10,000 (derivative) @ $0 · Disposition to issuer (D): 48,500 (derivative) @ $0 · Disposition to issuer (D): 48,500 (derivative) @ $0 · Disposition to issuer (D): 48,500 (derivative) @ $4.81 | EDGAR |
| 2021-08-30 | 4 | Lien Lyndon — Director | Disposition to issuer (D): 47,000 (derivative) @ $4.17 | EDGAR |
| 2021-08-30 | 4 | Liu Nanxi — Director | Disposition to issuer (D): 48,000 (derivative) @ $4.17 | EDGAR |
| 2021-08-30 | 4 | Elanco Animal Health Inc — 10% owner | Purchase (P): 45,508,938 @ $9.25 | EDGAR |
| 2021-08-30 | 4 | Wee Wendy — Chief Financial Officer | Disposition to issuer (D): 78,613 @ $9.25 · Disposition to issuer (D): 32,500 (derivative) @ $2.29 · Disposition to issuer (D): 10,000 (derivative) @ $6 · Disposition to issuer (D): 75,000 (derivative) @ $2.85 · Disposition to issuer (D): 50,000 (derivative) @ $2.15 · Disposition to issuer (D): 75,000 (derivative) @ $0.50 · +3 more | EDGAR |
| 2021-08-30 | 4 | Chin Richard — Chief Executive Officer, Director | Disposition to issuer (D): 1,709,271 @ $9.25 · Disposition to issuer (D): 2,000 @ $9.25 · Disposition to issuer (D): 2,000 @ $9.25 · Disposition to issuer (D): 2,000 @ $9.25 · Disposition to issuer (D): 2,000 @ $9.25 · Disposition to issuer (D): 400,000 (derivative) @ $8.89 · +8 more | EDGAR |
| 2021-08-30 | 4 | MONTGOMERY HERBERT D — Director | Disposition to issuer (D): 27,500 (derivative) @ $5.73 · Disposition to issuer (D): 3,350 (derivative) @ $5.11 · Disposition to issuer (D): 49,900 (derivative) @ $2.85 · Disposition to issuer (D): 75,000 (derivative) @ $0.50 · Disposition to issuer (D): 51,500 (derivative) @ $0 · Disposition to issuer (D): 51,500 (derivative) @ $0 · +1 more | EDGAR |
| 2021-08-04 | 4 | Chin Richard — Chief Executive Officer, Director | Gift (G): 320,000 @ $0 · Sale (S): 40,000 @ $9.21 | EDGAR |
| 2021-07-07 | 4 | Chin Richard — Chief Executive Officer, Director | Sale (S): 40,000 @ $9.18 | EDGAR |
| 2021-06-17 | 4 | Chin Richard — Chief Executive Officer, Director | Sale (S): 40,000 @ $9.18 | EDGAR |
| 2021-06-07 | 4 | Park West Asset Management LLC — 10% owner | Sale (S): 69,600 @ $6.80 · Sale (S): 345,383 @ $6.95 | EDGAR |
| 2021-03-18 | 4 | Bevers Denise — Director | Option exercise (M): 8,396 @ $0.32 · Sale (S): 8,396 @ $5.00 · Option exercise (M): 8,396 (derivative) @ $0 | EDGAR |
| 2021-02-23 | 4 | Bevers Denise — Director | Option exercise (M): 5 @ $0.32 · Sale (S): 5 @ $5 · Option exercise (M): 4,622 @ $0.32 · Sale (S): 4,622 @ $5 · Option exercise (M): 5 (derivative) @ $0 · Option exercise (M): 4,622 (derivative) @ $0 | EDGAR |
| 2021-02-09 | 4 | Lien Lyndon — Director | Grant/award (A): 47,000 (derivative) @ $0 | EDGAR |
| 2021-02-09 | 4 | Liu Nanxi — Director | Grant/award (A): 48,000 (derivative) @ $0 | EDGAR |
| 2021-02-09 | 4/A | Liu Nanxi — Director | Grant/award (A): 48,000 (derivative) @ $0 | EDGAR |
| 2021-02-03 | 4 | Chin Richard — Chief Executive Officer, Director | Option exercise (M): 12,500 · Tax withholding (F): 6,582 @ $5 · Option exercise (M): 12,500 (derivative) @ $0 | EDGAR |
| 2021-02-01 | 4 | Park West Asset Management LLC — 10% owner | Sale (S): 210,472 @ $5.25 · Sale (S): 3,300 @ $5.07 | EDGAR |
| 2021-01-26 | 4 | Zhan Hangjun — Chief Scientific Officer | Option exercise (M): 6,250 · Tax withholding (F): 3,385 @ $4.93 · Tax withholding (F): 3,385 @ $4.93 · Option exercise (M): 6,250 (derivative) @ $0 | EDGAR |
| 2021-01-26 | 4 | Wee Wendy — Chief Financial Officer | Option exercise (M): 7,500 · Tax withholding (F): 4,062 @ $4.93 · Tax withholding (F): 3,385 @ $4.93 · Option exercise (M): 7,500 (derivative) @ $0 | EDGAR |
| 2021-01-26 | 4 | Chin Richard — Chief Executive Officer, Director | Option exercise (M): 37,500 · Tax withholding (F): 19,744 @ $4.93 · Tax withholding (F): 13,163 @ $4.93 · Option exercise (M): 37,500 (derivative) @ $0 | EDGAR |
| 2021-01-22 | 4 | Veszpremi Ervin — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2021-01-22 | 4 | McCracken Joseph S — Director | Grant/award (A): 48,500 (derivative) @ $0 | EDGAR |
| 2021-01-22 | 4 | Townsend Raymond — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2021-01-22 | 4 | Bevers Denise — Director | Grant/award (A): 46,000 (derivative) @ $0 | EDGAR |
| 2021-01-22 | 4 | MARIO ERNEST — Director | Grant/award (A): 49,000 (derivative) @ $0 | EDGAR |
| 2021-01-22 | 4 | MONTGOMERY HERBERT D — Director | Grant/award (A): 51,500 (derivative) @ $0 | EDGAR |
| 2021-01-20 | 4 | Zhan Hangjun — Chief Scientific Officer | Option exercise (M): 6,250 · Tax withholding (F): 3,385 @ $4.95 · Option exercise (M): 6,250 (derivative) @ $0 · Grant/award (A): 83,500 (derivative) @ $0 | EDGAR |
| 2021-01-20 | 4 | Wee Wendy — Chief Financial Officer | Option exercise (M): 6,250 · Tax withholding (F): 3,385 @ $4.95 · Option exercise (M): 6,250 (derivative) @ $0 · Grant/award (A): 83,500 (derivative) @ $0 | EDGAR |
| 2021-01-20 | 4 | Chin Richard — Chief Executive Officer, Director | Option exercise (M): 37,500 · Tax withholding (F): 21,128 @ $4.95 · Option exercise (M): 37,500 (derivative) @ $0 · Grant/award (A): 394,000 (derivative) @ $0 | EDGAR |
| 2021-01-15 | 4 | Bevers Denise — Director | Option exercise (M): 13,023 @ $0.32 · Sale (S): 13,023 @ $5 · Option exercise (M): 13,023 (derivative) @ $0 | EDGAR |
| 2021-01-08 | 4 | Bevers Denise — Director | Option exercise (M): 15,502 @ $0.32 · Option exercise (M): 23,567 @ $0.32 · Sale (S): 39,069 @ $5.00 · Option exercise (M): 15,502 (derivative) @ $0 · Option exercise (M): 23,567 (derivative) @ $0 | EDGAR |
| 2020-10-08 | 4 | Bevers Denise — Director | Option exercise (M): 12,508 @ $0.32 · Sale (S): 12,508 @ $5.01 · Option exercise (M): 12,508 (derivative) @ $0 | EDGAR |
| 2020-09-24 | 4 | Bevers Denise — Director | Option exercise (M): 515 @ $0.32 · Sale (S): 515 @ $5 · Option exercise (M): 515 (derivative) @ $0 | EDGAR |
Recent 8-K events — Kindred Biosciences, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2021-08-30 | 8-K | 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-08-26 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2021-08-02 | 8-K | 8.01 — Other Events | EDGAR |
| 2021-07-01 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-06-24 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2021-06-16 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-06-02 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-05-11 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-04-20 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-03-16 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=KIN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs